Back to Search
SANDRA FRIZELLE, MD
MD
Research Study Specialist
NPI: 1215171095Individual
Specialties, Licenses & Credentials
Research Study SpecialistPrimary
Specialist — Research Study
Code: 1744R1102X
Research & Publications (7)
Gene therapy of established mesothelioma xenografts with recombinant p16INK4a adenovirus.
PMID 11129284·Cancer Gene Ther·2000
7-preclinical
Effects of insulin-like growth factor-1 receptor inhibition in mesothelioma. Thoracic Surgery Directors Association Resident Research Award.
PMID 16928523·Ann Thorac Surg·2006
4-observational
Repression of cap-dependent translation attenuates the transformed phenotype in non-small cell lung cancer both in vitro and in vivo.
PMID 16618749·Cancer Res·2006
7-preclinical
Gene expression profiling identifies matriptase overexpression in malignant mesothelioma.
PMID 15136399·Chest·2004
8-other
Mechanisms of G1 checkpoint loss in resected early stage non-small cell lung cancer.
PMID 11282426·Lung Cancer·2001
8-other
Evidence for colorectal cancer micrometastases using reverse transcriptase-polymerase chain reaction analysis of MUC2 in lymph nodes.
PMID 10757125·Cancer Detect Prev·2000
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5217 2ND AVE S
MINNEAPOLIS, MN 55419 - Phone
- (612) 824-3001
Quick Facts
- NPI
- 1215171095
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 7
Are you this provider?
Claim Your Profile